US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

34.96

-0.1032-0.29%

Post-market: 34.960.00000.00%16:10 EDT

Volume:2K

Turnover:66.28K

Market Cap:16.43M

PE:- -

High:35.10

Open:35.10

Low:34.96

Close:35.06

52wk High:37.90

52wk Low:28.87

Shares:469.95K

Float Shares:469.95K

Volume Ratio:0.73

T/O Rate:0.40%

Dividend:0.41

Dividend Rate:1.17%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

AlzeCure Pharma to Present at Aktiedagen Event in Stockholm

Novartis's Latest Trial Setback Sinks Stock

Novartis Genetic Muscle Disorder Drug Fails Phase 3 Trial; Shares Drop Pre-Bell

MT Newswires Live

Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026

United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday

Benzinga Earnings

Novartis's Latest Trial Failure is Second Pipeline Setback in a Row

2026 Health and Life Sciences Conference Concludes Successfully in Guangzhou, Driving Bay Area Synergy and Global Partnerships

China Securities Reports Medical Device Sector Sustains Earnings Improvement While Medical Services Revenue Grows Steadily

European Equities Remain Flat as Energy Gains Offset by Pharma Slump

Novartis AG Falls Monday, Underperforms Market

Citi says Novartis news increases likelihood Crispr prioritizes next-gen CTX321

Citi sees limited immediate downside for Ionis after pelacarsen failure

BofA sees low single-digit percentage downside for Novartis on pelacarsen miss

Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market

Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference

ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review

Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial

Novartis India to Acquire 'Minipress' Trademarks from Pfizer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/MEDX/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":34.9572,"timestamp":1789156800000,"preClose":35.0604,"halted":0,"volume":1892,"hourTrading":{"tag":"盘后","latestPrice":34.9572,"preClose":34.9572,"latestTime":"16:10 EDT","volume":9,"amount":314.22879,"timestamp":1789157404707,"change":0,"changeRate":0,"amplitude":0.002208},"delay":0,"changeRate":-0.002943491802717626,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"Post-Mkt","change":-0.1032,"latestTime":"09-11 17:42:24 EDT","open":35.1,"high":35.1,"low":34.9572,"amount":66279,"amplitude":0.004073,"askPrice":35.65,"askSize":1,"bidPrice":34,"bidSize":25,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789171200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":35.0604,"sharesOutstanding":569946,"nav":35.21,"aum":16546798.66,"dividendRate":0.011734,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.9572,"preClose":34.9572,"latestTime":"16:10 EDT","volume":9,"amount":314.22879,"timestamp":1789157404707,"change":0,"changeRate":0,"amplitude":0.002208},"volumeRatio":0.731236},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.731236,"shares":469946,"dividePrice":0.4102,"high":35.1,"amplitude":0.004073,"preClose":35.0604,"low":34.9572,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":34.9572,"committee":0.923077,"eps":0,"divideRate":0.011734,"volume":1892,"delay":0,"ttmEps":0,"open":35.1,"prevYearClose":33.2024,"prevWeekClose":36.6906,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":37.0834,"twentyDayClose":35.9599,"sixtyDayClose":34.1895},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665323952","title":"AlzeCure Pharma to Present at Aktiedagen Event in Stockholm","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323952","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665323952?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:03","pubTimestamp":1788854584,"startTime":"0","endTime":"0","summary":"AlzeCure Pharma to present at Aktiedagen event in StockholmAlzeCure will present at Aktiespararna’s Aktiedagen in Stockholm on Sept. 15.CEO Martin Jnsson is scheduled to speak at 16:25 CEST at Birger ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL83QQ0r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKDWB100.SGD","SGXZ99366536.SGD","ELIL","LU2237443465.HKD","LU1069344957.HKD","LU1988902786.USD","LU2471134952.CNY","LU2491050071.SGD","IE00BJJMRY28.SGD","IE00BKPKM429.USD","LU0061475181.USD","LU0964807845.USD","LU1974910355.USD","LU2491050154.USD","LU2491049909.HKD","FTXH","LU2746668974.SGD","LU2471134796.USD","BK4534","LU1093756168.USD","LU0471298694.HKD","LU2236285917.USD","LU0109391861.USD","SGXZ51526630.SGD","LU2168564222.USD","IE00B4JS1V06.HKD","LU0354030438.USD","LU1127390331.HKD","LU2357305700.SGD","SG9999015945.SGD","LU1057294990.SGD","LU0820561818.USD","IE00B2B36J28.USD","LU0133085943.USD","LU2089284900.SGD","LU2756315664.SGD","IE00BFSS7M15.SGD","LU2237443382.USD","LU0058720904.USD","LU2089984988.USD","LU0787776722.HKD","LU0006306889.USD","IE0002141913.USD","LU0345770993.USD","LU0106261372.USD","LU0882574055.USD","LU2023250504.SGD","LU0708995401.HKD","LU2471134879.HKD","LU2168564065.EUR","TMED","BK4516","LU2106854487.HKD","IHE","IE0001KFT4U8.USD","IE0005OL40V9.USD","LU0096364046.USD","LU1814569148.SGD","LU1917777945.USD","IE00BJJMRX11.SGD","LU2265009873.SGD","IE0004445239.USD","IE00BN29S564.USD","IE00B775H168.HKD","LU1983299246.USD","LU0158827948.USD","LU0417517546.SGD","IE00BWXC8680.SGD","MEDI","LU2461242641.AUD","LU2462157665.USD","LU2756315318.SGD","LU2063271972.USD","LU1868837136.USD","GB00BDT5M118.USD","HRTS","LU1629891620.HKD","LU0882574139.USD","CURE","AGNG","LU1267930730.SGD","JDOC","LU2168564495.EUR","SG9999018857.SGD","LU0079474960.USD","LU2896262040.SGD","LU2361044865.SGD","LU2237443895.HKD","LU0320765059.SGD","LU2456880835.USD","LU0354030511.USD","LU0266013472.USD","BK4588","IE00B1BXHZ80.USD","LU0097036916.USD","LU2552382058.USD","LU0353189680.USD","TRUH","LU0786609619.USD","SG9999001176.USD","LU1868836591.USD","LU0471298777.SGD","SG9999014914.USD","IE0009355771.USD","LU0174119429.USD","LLYZ","LU2264538146.SGD","LU0345770308.USD","IE00BJJMRZ35.SGD","LU0316494557.USD","LU2361044949.HKD","IE00B4R5TH58.HKD","LU0683600562.USD","LU2211815571.USD","WDNA","RXL","LU0466842654.USD","PJP","LU0823434740.USD","LU0210536198.USD","LU1720051017.SGD","LU2213496289.HKD","LLY","SG9999014880.SGD","LU1548497426.USD","LU0456855351.SGD","LU0203201768.USD","LU1989771016.USD","IE00B1XK9C88.USD","LU2471134523.USD","SG9999015978.USD","BK4581","LU1720051108.HKD","MHIP","LU1232071149.USD","LU1291159041.SGD","LU1551013342.USD","IE00BJT1NW94.SGD","LU0203202063.USD","LU0094547139.USD","LU2108987350.USD","SGXZ81514606.USD","LU0640476718.USD","LU1979441026.SGD","LU0432979614.USD","LU0820561909.HKD","BK4585","LU0323591593.USD","LU2028103732.USD","VHT","LU0198837287.USD","LU2087625088.SGD","SG9999015952.SGD","LU1093756325.SGD","SG9999018865.SGD","LU2111349929.HKD","IE00B7KXQ091.USD","IE00BJLML261.HKD","LLYX","LU0109394709.USD","LU0158827781.USD","LU2089283258.USD","FHLC","LU1061106388.HKD","LU0353189763.USD","MEDX","OZEM","SGXZ57979304.SGD","ILDR","LU2237443549.SGD","LU1064131342.USD","LU0823416689.USD","LU1868836757.USD","LU2462591350.SGD","IE00BK4W5L77.USD","IXJ","LU2023250330.USD","SG9999001176.SGD","LU2271345857.HKD","LU0238689110.USD","LU1868836914.USD","LU2112291526.USD","IE00BFSS8Q28.SGD","LU1023059063.AUD","CANC","LU2237443978.SGD","LU0689472784.USD","LU2750360997.AUD","LU1323610961.USD","IE0004445015.USD","LU1623119135.USD","LU1868837300.USD","LU0823434583.USD","LU0943347566.SGD","SG9999013999.USD","LU2361045086.USD","LU2417539215.USD","LU0114720955.EUR","BK4007","LU0122379950.USD","LU0320765992.SGD","LU0672654240.SGD","BK4533","LU2168563687.JPY","LU2468319806.SGD","PPH","LU2552382132.HKD","LU1145028129.USD","LU2168564149.EUR","LU2237438978.USD","SGXZ31699556.SGD","LU1280957306.USD","LU2746668461.USD","LU0234572021.USD","IYH","LLII","IE00BFTCPJ56.SGD","LU0256863811.USD","LU2552382215.SGD","LU2750360641.GBP","SG9999014906.USD","LU2324357040.USD","LU0225283273.USD","SG9999014898.SGD","LU0889565916.HKD","GDOC","LU1366192091.USD","LU1804176565.USD","LU1035775433.USD","THNR","LU0289739699.SGD","LU1551013425.SGD","ELIS","LU2360106947.USD","BK4599","LU1691799644.USD","LU0256863902.USD","LU0385154629.USD","LU1712237335.SGD","SG9999015986.USD","LU2602419157.SGD","LU0820562030.AUD","SG9999017495.SGD","LU2023251221.USD","IE00BK4W5M84.HKD","XLV","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665323985","title":"Novartis's Latest Trial Setback Sinks Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323985","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665323985?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:01","pubTimestamp":1788854460,"startTime":"0","endTime":"0","summary":"Novartis shares plunged after the Swiss drugmaker said an experimental neuromuscular medicine missed the primary goal in a late-stage clinical trial, the latest blow to its efforts to find new growth ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NVS","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","PPH","IE0002141913.USD","IE0009355771.USD","LU0070302665.USD","MEDX","BK4588","BK4532","IE00BFTCPJ56.SGD","BK4007","BK4578","LU0320765489.SGD","LU0208291251.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665323534","title":"Novartis Genetic Muscle Disorder Drug Fails Phase 3 Trial; Shares Drop Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323534","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665323534?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:58","pubTimestamp":1788854332,"startTime":"0","endTime":"0","summary":"Novartis  said Tuesday its phase 3 Harbor study evaluating delpacibart etedesiran in patients with myotonic dystrophy type 1 failed to meet its primary endpoint of video hand opening time.The drug candidate for the genetic muscular disorder displayed signs of clinical activity for its secondary endpoints measuring muscle strength, daily living activities, and mobility during the trial, the company said.The company is analyzing the full dataset to decide future development plans while maintaining its five-year annual sales growth target of 5% to 6% through 2030, Novartis said.Shares of the company were down by more than 13% in Tuesday premarket activity.Price: 138.80, Change: -21.19, Percent Change: -13.24","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4588","MEDX","IE00B4R5TH58.HKD","BK4585","IE0009355771.USD","IE00B2B36J28.USD","LU0211331839.USD","LU0070302665.USD","PPH","NVS","BK4578","LU0208291251.USD","BK4532","IE00BJJMRZ35.SGD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665157325","title":"Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665157325","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665157325?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:30","pubTimestamp":1788852600,"startTime":"0","endTime":"0","summary":"– Verekitug, 100 mg dosed every 12 weeks, reduced AAER by 56% compared to placebo in patients with severe asthma – – Verekitug also delivered clinically meaningful improvements in lung function (FEV1)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357341/0/en/upstream-bio-presents-results-from-the-phase-2-valiant-trial-of-verekitug-for-the-treatment-of-severe-asthma-in-oral-presentation-at-ers-congress-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLS","09366","07366","IDNA","TSLI","TSLY","TEST","HYLG","TSLO","TSDD","GDOC","ELOL","TSLP","09766","TSLQ","CRSH","TSYY","MEDX","07766","TESC","TSII","TSLW","NVIB","TESL","TSL","TSLG","TLA","TSLT","TSLR","TSLZ","TSLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665402063","title":"United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2665402063","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665402063?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:11","pubTimestamp":1788851511,"startTime":"0","endTime":"0","summary":"Stocks in focus: UNFI and ABM earnings, Novartis trial miss, Co-Diagnostics CFO change, and Casey’s earnings expected.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/26/09/61650635/united-natural-foods-abm-industries-and-3-stocks-to-watch-heading-into-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4120","BK4007","IE00B2B36J28.USD","LU0708995401.HKD","FXG","LU0070302665.USD","IE0009355771.USD","BK4113","BK4578","IE00BFTCPJ56.SGD","CASY","LU0109391861.USD","NVS","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0320765489.SGD","IE0002141913.USD","DECU","BK4588","RGLO","IE00BJT1NW94.SGD","CODX","PMDE","GXDW","BK4532","LU0320765059.SGD","BK4102","IE0009354923.USD","PPH","UNFI","VGFPF","LU1267930730.SGD","ABM","BK4082","FEBU","LU1878469433.USD","JOYT","VOTE","BK4568","BK4585","LU0672654240.SGD","LU0208291251.USD","MEDX","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665034034","title":"Novartis's Latest Trial Failure is Second Pipeline Setback in a Row","url":"https://stock-news.laohu8.com/highlight/detail?id=2665034034","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665034034?lang=en_us&edition=fundamental","pubTime":"2026-09-08 14:46","pubTimestamp":1788849960,"startTime":"0","endTime":"0","summary":"0646 GMT - Novartis just suffered its second major pipeline setback in the past week after a drug candidate it acquired through its recent $12 billion Avidity Biosciences deal failed in a late-stage study, Vontobel's Stefan Schneider says in a research note. News that experimental drug del-desiran missed the goal in a trial for neuromuscular disease myotonic dystrophy type 1 comes after the Swiss pharmaceutical company last week reported disappointing results for cardiovascular medicine pelacarsen. Vontobel had forecast annual peak sales from del-desiran at $3 billion, with a 50% chance of reaching them, and now removes this forecast from its model. As a result, Vontobel cuts its target price on Novartis stock to 125 Swiss francs from 128 francs. Novartis shares closed at 125.46 francs on Monday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","IE0009355771.USD","BK4007","NVS","LU0211331839.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","BK4532","BK4578","LU0320765489.SGD","LU0208291251.USD","BK4588","IE00BJJMRZ35.SGD","PPH","IE00B2B36J28.USD","BK4585","MEDX","IE00BFTCPJ56.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103095218","title":"2026 Health and Life Sciences Conference Concludes Successfully in Guangzhou, Driving Bay Area Synergy and Global Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=1103095218","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103095218?lang=en_us&edition=fundamental","pubTime":"2026-09-08 12:01","pubTimestamp":1788840064,"startTime":"0","endTime":"0","summary":"On September 4, 2026, the \"2026 Health and Life Sciences Conference,\" themed \"Focusing on Bay Area Synergy and Expanding International Cooperation,\" was successfully held in Guangzhou. The event was...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MVP","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106413707","title":"China Securities Reports Medical Device Sector Sustains Earnings Improvement While Medical Services Revenue Grows Steadily","url":"https://stock-news.laohu8.com/highlight/detail?id=1106413707","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106413707?lang=en_us&edition=fundamental","pubTime":"2026-09-08 11:34","pubTimestamp":1788838468,"startTime":"0","endTime":"0","summary":"China Securities has released a research note indicating that the medical device sector maintained its revenue growth trajectory in Q2, with quarterly profit growth turning positive for the first...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","LGHT","09996","601066","BK0276","LNGR","GDOC","BK1583","IEIH","159883","MEDX","BK1574","PTH","RSPH","HART","BK1100","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193693103","title":"European Equities Remain Flat as Energy Gains Offset by Pharma Slump","url":"https://stock-news.laohu8.com/highlight/detail?id=1193693103","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193693103?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:30","pubTimestamp":1788798644,"startTime":"0","endTime":"0","summary":"European markets closed Monday with little movement, as rising crude prices and a sharp decline in a major pharmaceutical firm counterbalanced each other. The benchmark Stoxx Europe 600 index...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQLT","DEEF","RFDI","RFEU","DDWM","PTIN","IBUF","RODE","BK4585","IMTM","RAYD","LU0320765489.SGD","IFV","XLEX","BKIE","JANI","KOKU","GSEU","PXJ","QEFA","BK4578","DFAX","GSIE","PQIN","IAUG","VIDI","MEDX","BK4020","DIG","RDMX","GLOF","GXUS","TACN","TLCI","IVAL","TIIV","JDVI","BINV","SPXT","PEJ","TPOR","FEDM","ICOW","PDEV","FEOE","BKCI","USOI","BK4550","BK4504","EFZ","ENHI","MFSI","NVS","OILK","SSXU","IDEV","PTEU","IE00BJT1NW94.SGD","IMAR","JPIN","IE0009355771.USD","BWET","IMAY","IJUN","ITOL","WCMI","IQDF","DWMF","QLVD","YSEP","EPIN","ACWX","USE","ISEP","BBIN","LU0211331839.USD","NUDM","VEFA","LU0070302665.USD","DFIC","ILOW","CGIE","IAPR","IE00BFTCPJ56.SGD","XEML","EPV","IDEQ","PPH","STXI","IDMY","RINT","WWJD","NBIE","DXIV","DINT","IEUR","REFA","OPPE","CWI","ARLI","IMOM","IFLR","HEFA","PXE","YMAR","ESIM","EAFG","ISWN","JULI","IMFL","ICPY","HAWX","BK4167","DBC","BK4570","CEFA","VDE","BBEU","FENI","SCHF","AVNM","BK4588","IDJN","NIHI","FFDI","AVSD","OEFA","VGK","VNIE","WCMG","EFO","IVSI","WTIU","BK4534","IQSI","MFDX","BAIV","ERX","YDEC","BK4582","INOV","QBIF","FDT","CGXU","DMXU","BUFI","DRIP","FINT","PIEQ","PIZ","PPIE","EUDG","OIH","TOUS","DUG","EFAX","BK4532","TOK","UGA","DTAN","XES","QBIV","TXUE","IGGY","PZIV","FHIL","BK4581","IE0002141913.USD","FSZ","UAE","DRLL","IDMO","IFEB","XEUR","PXF","EWN","FEP","BNO","IXC","GLBL","GIEQ","DBO","XW","EFA","GSID","OVF","GUSH","IEV","FDEV","SEIE","USL","INTF","AIVI","DBE","MOTI","BUFY","FTXN","IEO","SPEU","VOOV","EURL","AVDE","TILC","AVIV","CVIE","IDEC","IE00B2B36J28.USD","SDOG","TLTD","UPV","VEU","JIRE","APIE","OAIM","UIVM","HFXI","IDUB","FEZ","IEFA","PGRI","JHMD","DBEF","BRIE","DMXF","FLEE","IOCT","DBEU","WEEI","DFAI","IJUL","RODM","URTH","FIEE","VEA","IE00B4R5TH58.HKD","EASG","CGIC","OILU","IJAN","IDME","IE00BJJMRZ35.SGD","LU0208291251.USD","OILT","TPIF","BK4007","IXUS","TDI","ISDX","SPDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317208","title":"Novartis AG Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317208","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317208?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:15","pubTimestamp":1788797700,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  dropped 3.2% to CHF125.46 Monday on what proved to be an overall unfavorable trading session for the stock market, with the Swiss Market Index SMI Index  falling 0.8% to 14,279.38.Novartis AG closed CHF7.22 short of its 52-week high of CHF132.68, which the company achieved on September 3, 2026.Trading volume was 3,077,526, compared to the 50-day average trading volume of 2,290,037.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B2B36J28.USD","MEDX","IE00BJJMRZ35.SGD","BK4578","PPH","LU0211331839.USD","LU0320765489.SGD","BK4532","IE0009355771.USD","LU0070302665.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0208291251.USD","BK4007","BK4588","NVS","IE0002141913.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665176793","title":"Citi says Novartis news increases likelihood Crispr prioritizes next-gen CTX321","url":"https://stock-news.laohu8.com/highlight/detail?id=2665176793","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665176793?lang=en_us&edition=fundamental","pubTime":"2026-09-07 23:20","pubTimestamp":1788794419,"startTime":"0","endTime":"0","summary":"After Novartis (NVS) reported that pelacarsen’s Phase 3 HORIZON study failed to demonstrate a statistically significant reduction in major adverse ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-says-novartis-news-increases-likelihood-crispr-prioritizes-next-gen-ctx321-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-says-novartis-news-increases-likelihood-crispr-prioritizes-next-gen-ctx321-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE00B2B36J28.USD","MEDX","IE00BJJMRZ35.SGD","BK4578","PPH","LU0211331839.USD","LU0320765489.SGD","BK4532","IE0009355771.USD","LU0070302665.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0208291251.USD","BK4007","BK4588","NVS","IE0002141913.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665552317","title":"Citi sees limited immediate downside for Ionis after pelacarsen failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2665552317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665552317?lang=en_us&edition=fundamental","pubTime":"2026-09-07 23:15","pubTimestamp":1788794109,"startTime":"0","endTime":"0","summary":"After Ionis’ (IONS) partner Novartis (NVS) disclosed that the pelacarsen Phase 3 Lp(a)HORIZON study failed to meet its primary endpoint of cardiova...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-sees-limited-immediate-downside-for-ionis-after-pelacarsen-failure-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-sees-limited-immediate-downside-for-ionis-after-pelacarsen-failure-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","LU0320765489.SGD","IE0002141913.USD","LU0211331839.USD","BK4585","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4532","NVS","LU0070302665.USD","LU0208291251.USD","MEDX","IE00B4R5TH58.HKD","BK4139","BK4007","IE00BJT1NW94.SGD","BK4588","IE0009355771.USD","BK4578","IONS","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311682","title":"BofA sees low single-digit percentage downside for Novartis on pelacarsen miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311682","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311682?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:00","pubTimestamp":1788782433,"startTime":"0","endTime":"0","summary":"After Novartis (NVS) announced pelacarsen missed its primary endpoint of reducing cardiovascular events in the Phase 3 HORIZON study, BofA sees low...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bofa-sees-low-single-digit-percentage-downside-for-novartis-on-pelacarsen-miss-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bofa-sees-low-single-digit-percentage-downside-for-novartis-on-pelacarsen-miss-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","BK4007","MEDX","BK4588","LU0320765489.SGD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0211331839.USD","BK4585","LU0208291251.USD","LU0070302665.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","PPH","BK4578","IE00B2B36J28.USD","BK4532","NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106718626","title":"Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1106718626","media":"Deep News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106718626?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:51","pubTimestamp":1788781895,"startTime":"0","endTime":"0","summary":"Jiangsu Aidea Pharmaceutical Group Co., Ltd. (688488) has disclosed its intention to participate in a collective earnings presentation tailored for the innovative drug sector on the STAR Market,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","KSTR","MEDX","BK1161","159992","BK0262","688488","LNGR","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143231072","title":"Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1143231072","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143231072?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:20","pubTimestamp":1788780027,"startTime":"0","endTime":"0","summary":"Remegen Co., Ltd. announced on September 7 that it will join the collective earnings communication session for the innovative drug industry on the STAR Market for the first half of 2026, scheduled...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","09995","IBBQ","LU1064130708.USD","06978","159992","LNGR","BK1583","BK0239","LU1969619763.USD","LU2328871848.SGD","LU2148510915.USD","LU1064131003.USD","LU2488822045.USD","KSTR","MEDX","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665023390","title":"ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2665023390","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665023390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:35","pubTimestamp":1788770131,"startTime":"0","endTime":"0","summary":"ASB Ventures-backed Boundary Zhikong’s Navista eVTOL navigation system enters CAAC airworthiness reviewShenzhen ASB Ventures portfolio company Boundary Intelligent Control secured CAAC acceptance of a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL7rkwzT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU2750360997.AUD","BK4599","LLII","LU1868837136.USD","LU0471298777.SGD","LU2264538146.SGD","IE00B4R5TH58.HKD","SGXZ81514606.USD","LU0882574055.USD","LU2108987350.USD","LU2552382215.SGD","IXJ","LU0106261372.USD","LU0234572021.USD","BK4534","LU2896262040.SGD","LU1623119135.USD","LU2357305700.SGD","THNR","LU2491050071.SGD","LU2468319806.SGD","LU2237438978.USD","LU2360106947.USD","LU2089283258.USD","LU2271345857.HKD","LU2237443895.HKD","LU2089984988.USD","SGXZ57979304.SGD","LU2491049909.HKD","LU1267930730.SGD","IE00B4JS1V06.HKD","SG9999015945.SGD","LU1093756325.SGD","LU2023250504.SGD","JDOC","IE00BJJMRZ35.SGD","ELIS","LU2168564065.EUR","PPH","IE00BK4W5L77.USD","IE0004445239.USD","LU1868836757.USD","LU2168564222.USD","CURE","LU1551013342.USD","LU2602419157.SGD","LU0353189763.USD","LU0210536198.USD","LU1868836591.USD","LU1127390331.HKD","IE0002141913.USD","BK4211","LU1323610961.USD","SG9999015978.USD","LU0289739699.SGD","FHLC","IE00BN29S564.USD","LU0820561818.USD","LU1548497426.USD","GB00BDT5M118.USD","LU2456880835.USD","LU1280957306.USD","LU2471134796.USD","LU2106854487.HKD","LU1868836914.USD","LU0345770993.USD","LU1979441026.SGD","IE00BFSS8Q28.SGD","LU1551013425.SGD","LU1989771016.USD","LU0323591593.USD","LU0061475181.USD","LU2361044949.HKD","SG9999018865.SGD","GDOC","LU1629891620.HKD","LU2112291526.USD","LU2471134952.CNY","LU2756315664.SGD","LU0708995401.HKD","SG9999014914.USD","LU0174119429.USD","LU0079474960.USD","LU0345770308.USD","LU0689472784.USD","LU1232071149.USD","IE00BJJMRX11.SGD","LU0417517546.SGD","LU0354030511.USD","LU1093756168.USD","LU0256863902.USD","LU2063271972.USD","LU1720051017.SGD","LU2237443382.USD","LU0238689110.USD","LU0889565916.HKD","LU2552382058.USD","LU0109394709.USD","LU2111349929.HKD","ASB","LU2461242641.AUD","LU1291159041.SGD","IE0005OL40V9.USD","LU1366192091.USD","MEDX","LU2028103732.USD","LU0320765059.SGD","LU2756315318.SGD","SG9999017495.SGD","LU0640476718.USD","MEDI","LU0096364046.USD","SG9999015986.USD","LU0058720904.USD","LU1720051108.HKD","LU2089284900.SGD","LU2023251221.USD","LLYZ","IE00BK4W5M84.HKD","IE00BKDWB100.SGD","LU0158827781.USD","LU0787776722.HKD","IE00BKPKM429.USD","LU0882574139.USD","IE00BJLML261.HKD","MHIP","IE0009355771.USD","LU0316494557.USD","LU0820562030.AUD","LU0256863811.USD","LU0266013472.USD","LU1974910355.USD","LU2237443549.SGD","LU1691799644.USD","LU0354030438.USD","IHE","LU2750360641.GBP","PJP","LU2023250330.USD","LU2471134879.HKD","LU0122379950.USD","HRTS","LU1814569148.SGD","BK4533","LU1023059063.AUD","LU2746668974.SGD","SG9999001176.SGD","BK4516","LU0203201768.USD","IE00B1BXHZ80.USD","IE0001KFT4U8.USD","VHT","LU1064131342.USD","IE00B775H168.HKD","LU1069344957.HKD","LU0823434740.USD","LU1988902786.USD","OZEM","ILDR","LU1983299246.USD","LU2462591350.SGD","LLY","LU0823416689.USD","SGXZ31699556.SGD","LU2471134523.USD","SG9999014906.USD","LU0353189680.USD","SGXZ99366536.SGD","LU0471298694.HKD","IE00BFTCPJ56.SGD","LU2211815571.USD","LU2237443978.SGD","LU2491050154.USD","LU2237443622.USD","AGNG","LU0198837287.USD","LU0225283273.USD","LU0823434583.USD","ELIL","IE00BWXC8680.SGD","LU2552382132.HKD","FTXH","LU0432979614.USD","LU1804176565.USD","LU0683600562.USD","CANC","SG9999014898.SGD","LU1917777945.USD","LU2417539215.USD","SG9999015952.SGD","WDNA","SGXZ51526630.SGD","SG9999018857.SGD","LU2168564149.EUR","LU2361045086.USD","LU0109391861.USD","SG9999014880.SGD","LU0006306889.USD","IE00B1XK9C88.USD","LU1712237335.SGD","IE00B2B36J28.USD","LU2265009873.SGD","LU0203202063.USD","LU0094547139.USD","LU1145028129.USD","LU0964807845.USD","LU0786609619.USD","LU1057294990.SGD","IE0004445015.USD","LU1868837300.USD","IE00BFSS7M15.SGD","LU2746668461.USD","IYH","SG9999013999.USD","LU0820561909.HKD","LU0466842654.USD","TRUH","XLV","LU2237443465.HKD","LU2361044865.SGD","LU0320765992.SGD","LU1035775433.USD","LU0672654240.SGD","LU2213496289.HKD","IE00B7KXQ091.USD","LU0456855351.SGD","LU2236285917.USD","SG9999001176.USD","IE00BJT1NW94.SGD","LU0097036916.USD","LU2462157665.USD","LU0133085943.USD","LU0385154629.USD","TMED","LU0158827948.USD","BK4581","IE00BJJMRY28.SGD","LLYX","RXL","LU2168564495.EUR","BK4007","BK4585","LU0943347566.SGD","LU2324357040.USD","LU2168563687.JPY","LU2087625088.SGD","LU1061106388.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182662414","title":"Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future","url":"https://stock-news.laohu8.com/highlight/detail?id=1182662414","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182662414?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:21","pubTimestamp":1788769307,"startTime":"0","endTime":"0","summary":"Shares of Zhejiang Anglikang Pharmaceutical Co.,Ltd. (002940.SZ) briefly hit the daily limit up on September 4th, buoyed by news of medical insurance negotiations and the launch of commercial...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","06978","002940","LNGR","BK1161","MEDX","IBBQ","BK1574","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390614","title":"Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390614","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390614?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768672,"startTime":"0","endTime":"0","summary":"UPDATE 2-Novartis cholesterol setback tests hopes for emerging heart disease drugsLONDON, Sept 7 (Reuters)-Shares of NovartisNOVN.Sfell more than 3% on Monday after its cholesterol drug failed in a cl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL1N44Z05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VHT","NAMS","LU2089284900.SGD","AMGN","MEDI","PPH","IYH","CURE","PBE","IE00BJJMRY28.SGD","LLYX","LLII","MHIP","SGXZ99366536.SGD","RXL","JDOC","SLN","HRTS","THNR","TMED","ILDR","LU0823434583.USD","ELIS","LLYZ","XLV","LU2361044865.SGD","BBH","CANC","TRUH","TBXU","ELIL","MEDX","WDNA","IBBQ","FTXH","LU0097036916.USD","LU2750360641.GBP","FHLC","PJP","LLY","LU1691799644.USD","BIB","LU1267930730.SGD","GDOC","LU1571399168.USD","IHE","OZEM","AGNG","IBB","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665572390","title":"Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665572390","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665572390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:03","pubTimestamp":1788768180,"startTime":"0","endTime":"0","summary":"Novartis shares fell after the Swiss drugmaker said an experimental medicine failed to reduce cardiovascular risk in a late-stage clinical trial.Shares in Novartis were down 3.2% in European morning t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","BK4007","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0320765489.SGD","IE00BJJMRZ35.SGD","NVS","MEDX","IE00BJT1NW94.SGD","BK4585","PPH","LU0208291251.USD","BK4578","IE00B4R5TH58.HKD","LU0211331839.USD","IE00B2B36J28.USD","BK4588","BK4532","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397422","title":"Novartis India to Acquire 'Minipress' Trademarks from Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397422","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397422?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:43","pubTimestamp":1788767020,"startTime":"0","endTime":"0","summary":"BRIEF-Novartis India To Acquire 'Minipress' Trademarks From PfizerSept 7 (Reuters)-Novartis India LtdNOIN.BO:TO ACQUIRE 'MINIPRESS' TRADEMARKS FROM PFIZERSource text:ID:nBSE74jJ9yFurther company coverage:NOIN.BO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44Y00E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","BK4578","IE00BJJMRZ35.SGD","LU0456855351.SGD","SG9999002224.SGD","PPH","IE0002141913.USD","IE0002270589.USD","IE00BLSP4239.USD","LU0070302665.USD","LU0225771236.USD","IE00B2B36J28.USD","BK4532","LU0321505439.SGD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","BK4568","LU0985481810.HKD","LU1057294990.SGD","LU1894683264.USD","LU2596442595.SGD","IE000M9KFDE8.USD","SGXZ57979304.SGD","MEDX","SG9999013999.USD","NVS","LU0211331839.USD","LU0320765489.SGD","IE00B19Z3581.USD","LU0225284248.USD","LU1023059063.AUD","LU0289739699.SGD","BK4533","BK4599","LU0234572021.USD","BK4588","IE00B3T34201.USD","OZEM","LU0208291251.USD","IE00BBT3K403.USD","LU1066053197.SGD","LU0306807586.USD","LU0868494617.USD","LU0122379950.USD","SG9999001176.SGD","SG9999011175.SGD","SG9999003800.SGD","LU0058720904.USD","IE0009355771.USD","BK4592","LU0170899867.USD","LU0321505868.SGD","BK4550","LU0306806265.USD","LU1066051498.USD","LU1883839398.USD","BK4534","SG9999002232.USD","PFE","IE00BJT1NW94.SGD","LU1894683348.USD","SG9999001176.USD","BK4585","IE00BFTCPJ56.SGD","BK4007","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":7,"totalSize":299,"code":"91000000","status":"200"}]}}